A New Method for Preparing Mesenchymal Stem Cells and Labeling with Ferumoxytol for Cell Tracking by MRI

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Liu, Li ^a   Tseng, Lanya ^a   Ye, Qing ^a,c   Wu, Yijen L ^a,d   Bain, Daniel J ^b   Ho, Chien ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNETITE;

ANIMAL; CELL SIZE; CELL TRACKING; CHEMISTRY; CYTOLOGY; MESENCHYMAL STEM CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGOCYTOSIS; PROCEDURES; RAT;

ANIMALS; CELL SIZE; CELL TRACKING; FERROSOFERRIC OXIDE; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELLS; PHAGOCYTOSIS; RATS;

EID: 84970028914     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26271     Document Type: Article

References (49)

1. Ho, C. & Hitchens, T. K. A non-invasive approach to detecting organ rejection by MRI: monitoring the accumulation of immune cells at the transplanted organ. Curr Pharm Biotechnol 5, 551-566 (2004).
2. Nguyen, P. K., Riegler, J. & Wu, J. C. Stem cell imaging: from bench to bedside. Cell Stem Cell 14, 431-444 (2014).
3. Wu, Y. L. et al. Magnetic resonance imaging investigation of macrophages in acute cardiac allograft rejection after heart transplantation. Circ Cardiovasc Imaging 6, 965-973 (2013).
4. Shapiro, E. M. et al. MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA 101, 10901-10906 (2004).
5. Bulte, J. W. In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol 193, 314-325 (2009).
6. Ye, Q. et al. Longitudinal tracking of recipient macrophages in a rat chronic cardiac allograft rejection model with noninvasive magnetic resonance imaging using micrometer-sized paramagnetic iron oxide particles. Circulation 118, 149-156 (2008).
7. Wu, Y. L. et al. In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. Proc Natl Acad Sci USA 103, 1852-1857 (2006).
8. Bulte, J. W. & Kraitchman, D. L. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17, 484-499 (2004).
9. Kanno, S. et al. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 104, 934-938 (2001).
10. Liu, L. et al. Tracking T-cells in vivo with a new nano-sized MRI contrast agent. Nanomedicine 8, 1345-1354 (2012).
11. Roach, D. R. et al. Magnetic cell labeling of primary and stem cell-derived pig hepatocytes for MRI-based cell tracking of hepatocyte transplantation. PLoS One 10, e0123282 (2015).
12. Noad, J. et al. MRI tracking of transplanted iron-labeled mesenchymal stromal cells in an immune-compromised mouse model of critical limb ischemia. NMR Biomed 26, 458-467 (2013).
13. Siegers, G. M., Ribot, E. J., Keating, A. & Foster, P. J. Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI. Cancer Immunol Immunother 62, 571-583 (2013).
14. Karantalis, V. & Hare, J. M. Use of Mesenchymal Stem Cells for Therapy of Cardiac Disease. Circ Res 116, 1413-1430 (2015).
15. Thomas, J. A. et al. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology 53, 2003-2015 (2011).
16. Chazaud, B. Macrophages: supportive cells for tissue repair and regeneration. Immunobiology 219, 172-178 (2014).
17. Anguille, S., Smits, E. L., Lion, E., van Tendeloo, V. F. & Berneman, Z. N. Clinical use of dendritic cells for cancer therapy. Lancet Oncol 15, E257-E267 (2014).
18. Perin, E. C. et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 307, 1717-1726 (2012).
19. Heldman, A. W. et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA 311, 62-73 (2014).
20. Hare, J. M. et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 308, 2369-2379 (2012).
21. Bolli, R. et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378, 1847-1857 (2011).
22. Bang, O. Y., Lee, J. S., Lee, P. H. & Lee, G. Autologous mesenchymal stem cell transplantation in stroke patients. Annals of Neurology 57, 874-882 (2005).
23. Alper, J. Geron gets green light for human trial of ES cell-derived product. Nat Biotechnol 27, 213-214 (2009).
24. Bianco, P. "Mesenchymal" stem cells. Annu Rev Cell Dev Biol 30, 677-704 (2014).
25. Chen, P. M., Yen, M. L., Liu, K. J., Sytwu, H. K. & Yen, B. L. Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J. Biomed Sci. 18, 49 (2011).
26. Yin, Y. et al. In vivo tracking of human adipose-derived stem cells labeled with ferumoxytol in rats with middle cerebral artery occlusion by magnetic resonance imaging. Neural Regener. Res 10, 909-915 (2015).
27. Khurana, A. et al. Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI. Nanomedicine (Lond) 8, 1969-1983 (2013).
28. Gutova, M. et al. Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use. Stem Cells Transl Med 2, 766-775 (2013).
29. Bashir, M. R., Bhatti, L., Marin, D. & Nelson, R. C. Emerging Applications for Ferumoxytol as a Contrast Agent in MRI. J Magn Reson Imaging 41, 884-898 (2015).
30. Lu, M., Cohen, M. H., Rieves, D. & Pazdur, R. FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease. Am J Hematol 85, 315-319 (2010).
31. Thu, M. S. et al. Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat Med 18, 463-467 (2012).
32. Khurana, A. et al. Iron administration before stem cell harvest enables MR imaging tracking after transplantation. Radiology 269, 186-197 (2013).
33. Bulte, J. W. Science to practice: can stem cells be labeled inside the body instead of outside? Radiology 269, 1-3 (2013).
34. Hoch, A. I. & Leach, J. K. Concise review: optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications. Stem Cells Transl Med 4, 412 (2015).
35. Kumamoto, M., Nishiwaki, T., Matsuo, N., Kimura, H. & Matsushima, K. Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury. Eur Respir J 34, 740-748 (2009).
36. Ng, C. P. et al. Enhanced ex vivo expansion of adult mesenchymal stem cells by fetal mesenchymal stem cell ECM. Biomaterials 35, 4046-4057 (2014).
37. Colter, D. C., Sekiya, I. & Prockop, D. J. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 98, 7841-7845 (2001).
38. Colter, D. C., Class, R., DiGirolamo, C. M. & Prockop, D. J. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 97, 3213-3218 (2000).
39. Christodoulou, I., Kolisis, F. N., Papaevangeliou, D. & Zoumpourlis, V. Comparative Evaluation of Human Mesenchymal Stem Cells of Fetal (Wharton's Jelly) and Adult (Adipose Tissue) Origin during Prolonged In Vitro Expansion: Considerations for Cytotherapy. Stem Cells Int 2013, 246134 (2013).
40. Estrada, J. C. et al. Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy. Cell Death Dis 4, e691 (2013).
41. Samsonraj, R. M. et al. Establishing criteria for human mesenchymal stem cell potency. Stem Cells 33, 1878-1891 (2015).
42. Zhang, W. et al. Comparisons of rabbit bone marrow mesenchymal stem cell isolation and culture methods in vitro. PLoS One 9, e88794 (2014).
43. Chen, C. L. et al. A new nano-sized iron oxide particle with high sensitivity for cellular magnetic resonance imaging. Mol Imaging Biol 13, 825-839 (2011).
44. Wang, W. B. et al. Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses. Stem Cell Reports 5, 392-404 (2015).
45. Hamilton, B. E. et al. Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging. AJR Am J Roentgenol 197, 981-988 (2011).
46. Travlos, G. S. Normal structure, function, and histology of the bone marrow. Toxicol Pathol 34, 548-565 (2006).
47. Li, X., Zhang, Y. & Qi, G. Evaluation of isolation methods and culture conditions for rat bone marrow mesenchymal stem cells. Cytotechnology 65, 323-334 (2013).
48. Soleimani, M. & Nadri, S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc 4, 102-106 (2009).
49. Liu, L. et al. Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid. Biochim Biophys Acta 1830, 3447-3453 (2013).